Furthermore, we reconstructed this scFv of PSMA into a human monoclonal PSMA antibody (PSMAb) and provided evidence that PSMAb could be specifically internalized into PSMA+ prostate cancer cells with high binding affinity in vitro and in vivo. The gene discussed is FOLH1; the disease is prostate carcinoma.